Hyderabad (Telangana) [India], February 20: GV Research Platform (GVRP) today announced a strategic distribution partnership with Yurogen Biosystems, a global life sciences company specialising in custom biologics development. The collaboration is aimed at expanding access for Indian biotech
Hyderabad (Telangana) [India], February 5: GV Safety Assessment Platform (GVSAP), an integrated preclinical R&D enabler within the GVRP portfolio, today announced an expansion of its strategic collaboration with Biocytogen (SSE: 688796; HKEX: 02315), a global biotechnology company that drive
New Delhi [India], January 29: Cupid Limited, (BSE - 530843, NSE - CUPID), a diversified Indian healthcare and consumer products company with a growing focus on in-vitro diagnostics (IVD),wellness, and personal care, announced that it has received CE (EU IVDR) Certification for two in-vitro
Singapore, November 26: Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar d
Mumbai (Maharashtra) [India], October 18: Cupid Limited, (BSE - 530843, NSE - CUPID), Cupid Limited, a leading Indian healthcare and diagnostics manufacturer, announced today that it has been granted CE (EU IVDR) Certification for two of its key in-vitro diagnostic (IVD) devices -- the CupiS
According to the Ministry of Science and Technology, a new property in the largest antibody goes on to change the existing understanding of antibodies from chemical keys that fit into microbial locks to mechanical engineers.
As per an official statement, the zoo has taken scientific biosafety measures and carried out disinfection, and started serosurveillance to map the animal's antibody levels against infectious disease.
Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and those who have suffered severe trauma, such as burns, blast injuries, or natural disaster victims.
Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being studied as an alternative to chemotherapy and radiotherapy. This is because it directly targets cancer cells, reducing the negative effects associated with more conventi
The antibodies target a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection. It helps in preventing severe bird flu in monkeys.
Researchers at Uppsala University and KTH Royal Institute of Technology have created an antibody that has the potential to treat a variety of cancers. Researchers were able to integrate three different functionalities in the antibody, which combined significantly increased the action of T ce